<em>Calotropis procera</em> Latex Extract Affords Protection  against Inflammation and Oxidative Stress in Freund's  Complete Adjuvant-Induced Monoarthritis in Rats

Kumar, Vijay L.; Roy, Sanjeev

doi:https://doi.org/10.1155/2007/47523

Mediators of Inflammation

On this page

Abstract References Copyright Related Articles

Research Article | Open Access

Volume 2007 | Article ID 047523 | https://doi.org/10.1155/2007/47523

Calotropis procera Latex Extract Affords Protection against Inflammation and Oxidative Stress in Freund's Complete Adjuvant-Induced Monoarthritis in Rats

Vijay L. Kumar¹and Sanjeev Roy¹

Received01 Dec 2006

Revised12 Feb 2007

Accepted12 Feb 2007

Published19 Mar 2007

Abstract

In view of the well-established anti-inflammatory properties of latex of Calotropis procera (DL), the present study was carried out to evaluate the protective effect of its methanol extract (MeDL) against inflammation and oxidative stress in monoarthritis induced by Freund's complete adjuvant (FCA) in rats. Intra-articular injection of FCA produced inflammation of the joint with a peak effect occurring on day 4 where a maximum increase in the levels of myeloperoxidase and inflammatory mediators like PGE2, TNF-α, and nitric oxide was observed. This was associated with oxidative stress with a marked reduction in the levels of glutathione, catalase, superoxide dismutase and glutathione peroxidase and an increase in the lipid peroxidation as indicated by the higher levels of thiobarbituric acid reactive substances (TBARSs). Subsequently on day 28 the histological analysis of the joint also revealed arthritic changes. Daily treatment of rats with MeDL (50 and 500 mg/kg) and standard anti-inflammatory drug rofecoxib (20 and 100 mg/kg), produced a significant attenuation in the inflammatory response and ameliorated the arthritic changes in the joint. The protection afforded by MeDL and rofecoxib was more pronounced than that of phenylbutazone and was associated with normalization of the levels of inflammatory mediators and biochemical parameters of oxidative stress. However, the overall protection afforded by rofecoxib was better than that of MeDL.

References

K. D. Brandt, “Osteoarthritis,” in Harrison's Principles of Internal Medicine, D. L. Kasper, E. Braunwald, A. S. Fauci, S. L. Hauser, D. L. Longo, and J. L. Jameson, Eds., vol. 2, pp. 2036–2045, McGraw-Hill, New York, NY, USA, 16th edition, 2005.
View at: Google Scholar
J. A. Markenson, “Worldwide trends in the socioeconomic impact and long-term prognosis of rheumatoid arthritis,” Seminars in Arthritis and Rheumatism, vol. 21, no. 2 supplement 1, pp. 4–12, 1991.
View at: Publisher Site | Google Scholar
P. H. Wooley, “Animal models of rheumatoid arthritis,” Current Opinion in Rheumatology, vol. 3, no. 3, pp. 407–420, 1991.
View at: Publisher Site | Google Scholar
C. M. Pearson, “Development of arthritis, periarthritis and periostitis in rats given adjuvants,” Proceedings of the Society for Experimental Biology and Medicine, vol. 91, no. 1, pp. 95–101, 1956.
View at: Google Scholar
P. A. Nigrovic and D. M. Lee, “Mast cells in inflammatory arthritis,” Arthritis Research and Therapy, vol. 7, no. 1, pp. 1–11, 2005.
View at: Publisher Site | Google Scholar
K.-I. Yamada, T. Nakamura, and H. Utsumi, “Enhanced intraarticular free radical reactions in adjuvant arthritis rats,” Free Radical Research, vol. 40, no. 5, pp. 455–460, 2006.
View at: Publisher Site | Google Scholar
S. M. Wahl, “The role of lymphokines and monokines in fibrosis,” Annals of the New York Academy of Sciences, vol. 460, no. 1, pp. 224–231, 1985.
View at: Publisher Site | Google Scholar
Z. Szekanecz, M. M. Halloran, and M. V. Volin et al., “Temporal expression of inflammatory cytokines and chemokines in rat adjuvant-induced arthritis,” Arthritis and Rheumatism, vol. 43, no. 6, pp. 1266–1277, 2000.
View at: Publisher Site | Google Scholar
S. B. Abramson, M. Attur, A. R. Amin, and R. Clancy, “Nitric oxide and inflammatory mediators in the perpetuation of osteoarthritis,” Current Rheumatology Reports, vol. 3, no. 6, pp. 535–541, 2001.
View at: Google Scholar
P. H. J. Remans, M. van Oosterhout, and T. J. M. Smeets et al., “Intracellular free radical production in synovial T lymphocytes from patients with rheumatoid arthritis,” Arthritis and Rheumatism, vol. 52, no. 7, pp. 2003–2009, 2005.
View at: Publisher Site | Google Scholar
W. D. Blackburn Jr., “Management of osteoarthritis and rheumatoid arthritis: prospects and possibilities,” The American Journal of Medicine, vol. 100, no. 2A, pp. 24S–30S, 1996.
View at: Google Scholar
J. K. Rao, K. Mihaliak, K. Kroenke, J. Bradley, W. M. Tierney, and M. Weinberger, “Use of complementary therapies for arthritis among patients of rheumatologists,” Annals of Internal Medicine, vol. 131, no. 6, pp. 409–416, 1999.
View at: Google Scholar
V. L. Kumar and S. Arya, “Medicinal uses and pharmacological properties of Calotropis procera,” in Recent Progress in Medicinal Plants, J. N. Govil, Ed., vol. 11, pp. 373–388, Studium Press, Houston, Tex, USA, 2006.
View at: Google Scholar
V. L. Kumar and N. Basu, “Anti-inflammatory activity of the latex of Calotropis procera,” Journal of Ethnopharmacology, vol. 44, no. 2, pp. 123–125, 1994.
View at: Publisher Site | Google Scholar
S. Dewan, H. Sangraula, and V. L. Kumar, “Preliminary studies on the analgesic activity of latex of Calotropris procera,” Journal of Ethnopharmacology, vol. 73, no. 1-2, pp. 307–311, 2000.
View at: Publisher Site | Google Scholar
S. Dewan, S. Kumar, and V. L. Kumar, “Antipyretic effect of latex of Calotropis procera,” Indian Journal of Pharmacology, vol. 32, no. 3, p. 252, 2000.
View at: Google Scholar
S. Arya and V. L. Kumar, “Antiinflammatory efficacy of extracts of latex of Calotropis procera against different mediators of inflammation,” Mediators of Inflammation, vol. 2005, no. 4, pp. 228–232, 2005.
View at: Publisher Site | Google Scholar
T. Choedon, G. Mathan, S. Arya, V. L. Kumar, and V. Kumar, “Anticancer and cytotoxic properties of the latex of Calotropis procera in a transgenic mouse model of hepatocellular carcinoma,” World Journal of Gastroenterology, vol. 12, no. 16, pp. 2517–2522, 2006.
View at: Google Scholar
Y. Wang, C. Huang, Y. Cao, and J.-S. Han, “Repeated administration of low dose ketamine for the treatment of monoarthritic pain in the rat,” Life Sciences, vol. 67, no. 3, pp. 261–267, 2000.
View at: Publisher Site | Google Scholar
H. Sangraula, S. Dewan, and V. L. Kumar, “Evaluation of anti-inflammatory activity of latex of Calotropis procera in different models of inflammation,” Inflammopharmacology, vol. 9, no. 3, pp. 257–264, 2002.
View at: Publisher Site | Google Scholar
V. L. Kumar, S. Roy, R. Sehgal, and B. M. Padhy, “A comparative study on the efficacy of rofecoxib in monoarticular arthritis induced by latex of Calotropis procera and Freund's complete adjuvant,” Inflammopharmacology, vol. 14, no. 1-2, pp. 17–21, 2006.
View at: Publisher Site | Google Scholar
G. L. Ellman, “Tissue sulfhydryl groups,” Archives of Biochemistry and Biophysics, vol. 82, no. 1, pp. 70–77, 1959.
View at: Publisher Site | Google Scholar
H. Aebi, “Catalase in vitro,” Methods in Enzymology, vol. 105, pp. 121–126, 1984.
View at: Google Scholar
P. Kakkar, B. Das, and P. N. Viswanathan, “A modified spectrophotometric assay of superoxide dismutase,” Indian Journal of Biochemistry and Biophysics, vol. 21, no. 2, pp. 130–132, 1984.
View at: Google Scholar
D. E. Paglia and W. N. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967.
View at: Google Scholar
H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979.
View at: Publisher Site | Google Scholar
D. Bilici, E. Akpinar, and A. Kiziltunç, “Protective effect of melatonin in carrageenan-induced acute local inflammation,” Pharmacological Research, vol. 46, no. 2, pp. 133–139, 2002.
View at: Publisher Site | Google Scholar
M. C. Calixto, K. M. Trichês, and J. B. Calixto, “Analysis of the inflammatory response in the rat paw caused by the venom of Apis melifera bee,” Inflammation Research, vol. 52, no. 3, pp. 132–139, 2003.
View at: Publisher Site | Google Scholar
M. M. Bradford, “A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding,” Analytical Biochemistry, vol. 72, no. 1-2, pp. 248–254, 1976.
View at: Publisher Site | Google Scholar
G. D. Anderson, S. D. Hauser, K. L. McGarity, M. E. Bremer, P. C. Isakson, and S. A. Gregory, “Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis,” Journal of Clinical Investigation, vol. 97, no. 11, pp. 2672–2679, 1996.
View at: Google Scholar
J. Keeble, M. Blades, C. Pitzalis, F. A. Castro Da Rocha, and S. D. Brain, “The role of substance P in microvascular responses in murine joint inflammation,” British Journal of Pharmacology, vol. 144, no. 8, pp. 1059–1066, 2005.
View at: Publisher Site | Google Scholar
B. Johnston, A. R. Burns, and P. Kubes, “A role for mast cells in the development of adjuvant-induced vasculitis and arthritis,” American Journal of Pathology, vol. 152, no. 2, pp. 555–563, 1998.
View at: Google Scholar
S. Kleinau, H. Erlandsson, and L. Klareskog, “Percutaneous exposure of adjuvant oil causes arthritis in DA rats,” Clinical and Experimental Immunology, vol. 96, no. 2, pp. 281–284, 1994.
View at: Google Scholar
F. F. Y. Lam, H. H. L. Wong, and E. S. K. Ng, “Time course and substance P effects on the vascular and morphological changes in adjuvant-induced monoarthritic rats,” International Immunopharmacology, vol. 4, no. 2, pp. 299–310, 2004.
View at: Publisher Site | Google Scholar
M. Di Rosa, J. P. Giroud, and D. A. Willoughby, “Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine,” Journal of Pathology, vol. 104, no. 1, pp. 15–29, 1971.
View at: Google Scholar
J. N. Francischi, C. T. Chaves, and A. C. L. Moura et al., “Selective inhibitors of cyclo-oxygenase-2 (COX-2) induce hypoalgesia in a rat paw model of inflammation,” British Journal of Pharmacology, vol. 137, no. 6, pp. 837–844, 2002.
View at: Publisher Site | Google Scholar
C.-C. Chan, S. Boyce, and C. Brideau et al., “Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: a novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach,” Journal of Pharmacology and Experimental Therapeutics, vol. 274, no. 3, pp. 1531–1537, 1995.
View at: Google Scholar
S. C. R. Meacock and E. A. Kitchen, “Some effects of non-steroidal anti-inflammatory drugs on leucocyte migration,” Agents and Actions, vol. 6, no. 1–3, pp. 320–325, 1976.
View at: Publisher Site | Google Scholar
J. H. Yen, J. R. Chen, W. J. Tsai, and H. W. Liu, “Correlation of tumor necrosis factor alpha levels with disease activity of rheumatoid arthritis,” Zhonghua Minguo wei sheng wu ji mian yi xue za zhi, vol. 25, no. 4, pp. 232–243, 1992.
View at: Google Scholar
L. Philippe, P. Gegout-Pottie, and C. Guingamp et al., “Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats,” American Journal of Physiology, vol. 273, no. 4, part 2, pp. R1550–R1556, 1997.
View at: Google Scholar
R. Kohen and A. Nyska, “Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification,” Toxicologic Pathology, vol. 30, no. 6, pp. 620–650, 2002.
View at: Publisher Site | Google Scholar
F. Karatas, I. Ozates, H. Canatan, I. Halifeoglu, M. Karatepe, and R. Colak, “Antioxidant status & lipid peroxidation in patients with rheumatoid arthritis,” Indian Journal of Medical Research, vol. 118, pp. 178–181, 2003.
View at: Google Scholar
A. Kamanli, M. Naziroǧlu, N. Aydilek, and C. Hacievliyagil, “Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis,” Cell Biochemistry and Function, vol. 22, no. 1, pp. 53–57, 2004.
View at: Publisher Site | Google Scholar
A. Dhir, S. S. V. Padi, P. S. Naidu, and S. K. Kulkarni, “Protective effect of naproxen (non-selective COX-inhibitor) or rofecoxib (selective COX-2 inhibitor) on immobilization stress-induced behavioral and biochemical alterations in mice,” European Journal of Pharmacology, vol. 535, no. 1–3, pp. 192–198, 2006.
View at: Publisher Site | Google Scholar
S. Roy, R. Sehgal, B. M. Padhy, and V. L. Kumar, “Antioxidant and protective effect of latex of Calotropis procera against alloxan-induced diabetes in rats,” Journal of Ethnopharmacology, vol. 102, no. 3, pp. 470–473, 2005.
View at: Publisher Site | Google Scholar

Copyright

Copyright © 2007 Vijay L. Kumar and Sanjeev Roy. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PDF Download Citation Order printed copies

Views

568

Downloads

1424

Citations